Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President
Oncology's Greatest Threat: A System in Crisis
Roche–Nurix $2.3 Billion Deal for BTK Degrader Bexobrutideg in Blood Cancers
15 Posts Not To Miss From ASCO 2026: Breast Edition
TESAR Trial: Adjuvant ChemoRT vs Completion TME After Local Excision for Early Rectal Cancer
Rethinking Care Beyond Cure Through the Lens of Palliative Medicine - CancerWorld
ESMO Updates Metastatic Breast Cancer Guideline: A More Molecular, Subtype-Driven Roadmap For Care
Long-Term Follow-Up of the CALGB 10403 Trial: New Insights into AYA ALL - Resonance
